Celldex Therapeutics, Inc. (NASDAQ:CLDX)
CAPS Rating:
A biopharmaceutical company engaged in the discovery, development and commercialization of products that harness the human immune response to prevent and treat disease.
RSS Headlines
Fool UK
Recs
great pipeline